MedPath

A Pilot Randomised Control Trial to determine the acceptability and feasibility of providing early intervention with the Omo Neurexa shoulder Orthoses when compared to usual practice, in reducing the development of Hemiplegic shoulder pain post stroke.

Not Applicable
Conditions
Stoke
Shoulder pain
Stroke - Haemorrhagic
Musculoskeletal - Other muscular and skeletal disorders
Stroke - Ischaemic
Registration Number
ACTRN12619000068167
Lead Sponsor
epean Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
10
Inclusion Criteria

First Cardiovascular Accident
Hemiparetic upper limb - manual muscle testing below 3/5 and unable to hold the shoulder at 90 degrees forward flexion for < 10 seconds.
No premorbid shoulder issues

Exclusion Criteria

Language or Cognitive deficits precluding the participant from being able to provide informed consent or self report on pain levels or issues with either device.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite outcome - Acceptability will be evaluated by the percentage of participants who, (1) agreed to participate, (2) complied with wearing the support for the allotted time period per day (3) attended the follow up assessments. This will be recorded in two ways (1) self-report using a questionnaire at the assessment intervals - see below. (2) study records[12 weeks post enrolment, assessed at 4 weekly intervals for 12 weeks post enrolment<br>];Composite outcome - Feasibility will be evaluated by (1) number of patients who met the inclusion criteria, (2) number of participants recruited from the total number screened, (3) Number of drop outs. This will be recorded via the study screening forms, consent forms and study records. [12 weeks post enrolment, assessed at 4 weekly intervals for 12 weeks post enrolment];Composite outcome - Delays in initial transfer out of bed and compliance of nursing staff applying the supports will be evaluated via a medical record review.[ 12 weeks post enrolment]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath